{"id":196863,"date":"2024-10-01T11:22:52","date_gmt":"2024-10-01T16:22:52","guid":{"rendered":"https:\/\/lifeboat.com\/blog\/2024\/10\/novel-fabp4c1q-macrophages-enhance-antitumor-immunity-and-associated-with-response-to-neoadjuvant-pembrolizumab-and-chemotherapy-in-nsclc-via-ampk-jak-stat-axis"},"modified":"2024-10-01T11:22:52","modified_gmt":"2024-10-01T16:22:52","slug":"novel-fabp4c1q-macrophages-enhance-antitumor-immunity-and-associated-with-response-to-neoadjuvant-pembrolizumab-and-chemotherapy-in-nsclc-via-ampk-jak-stat-axis","status":"publish","type":"post","link":"https:\/\/lifeboat.com\/blog\/2024\/10\/novel-fabp4c1q-macrophages-enhance-antitumor-immunity-and-associated-with-response-to-neoadjuvant-pembrolizumab-and-chemotherapy-in-nsclc-via-ampk-jak-stat-axis","title":{"rendered":"Novel FABP4+C1q+ macrophages enhance antitumor immunity and associated with response to neoadjuvant pembrolizumab and chemotherapy in NSCLC via AMPK\/JAK\/STAT axis"},"content":{"rendered":"<p><a class=\"aligncenter blog-photo\" href=\"https:\/\/lifeboat.com\/blog.images\/novel-fabp4c1q-macrophages-enhance-antitumor-immunity-and-associated-with-response-to-neoadjuvant-pembrolizumab-and-chemotherapy-in-nsclc-via-ampk-jak-stat-axis.jpg\"><\/a><\/p>\n<p>Immune checkpoint inhibitors (ICIs) immunotherapy facilitates new approaches to achieve precision cancer treatment.<\/p>\n<hr>\n<p>Zhang, D., Wang, M., Liu, G. <i>et al.<\/i> Novel FABP4<sup>+<\/sup>C1q<sup>+<\/sup> macrophages enhance antitumor immunity and associated with response to neoadjuvant pembrolizumab and chemotherapy in NSCLC via AMPK\/JAK\/STAT axis. <i>Cell Death Dis<\/i> <b>15<\/b>, 717 (2024). <a href=\"https:\/\/doi.org\/10.1038\/s41419-024-07074-x\">https:\/\/doi.org\/10.1038\/s41419-024-07074-x<\/a>.<\/p>\n<p><a data-test=\"citation-link\" data-track=\"click\" data-track-action=\"download article citation\" data-track-label=\"link\" data-track-external=\"\" rel=\"nofollow\" href=\"https:\/\/citation-needed.springer.com\/v2\/references\/10.1038\/s41419-024-07074-x?format=refman&flavour=citation\">Download citation<\/a>.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Immune checkpoint inhibitors (ICIs) immunotherapy facilitates new approaches to achieve precision cancer treatment. Zhang, D., Wang, M., Liu, G. et al. Novel FABP4+C1q+ macrophages enhance antitumor immunity and associated with response to neoadjuvant pembrolizumab and chemotherapy in NSCLC via AMPK\/JAK\/STAT axis. Cell Death Dis 15, 717 (2024). https:\/\/doi.org\/10.1038\/s41419-024-07074-x. Download citation.<\/p>\n","protected":false},"author":534,"featured_media":0,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[11],"tags":[],"class_list":["post-196863","post","type-post","status-publish","format-standard","hentry","category-biotech-medical"],"_links":{"self":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts\/196863","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/users\/534"}],"replies":[{"embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/comments?post=196863"}],"version-history":[{"count":0,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts\/196863\/revisions"}],"wp:attachment":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/media?parent=196863"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/categories?post=196863"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/tags?post=196863"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}